The use of botulinum toxin in the treatment of adductor spasmodic dysphonia.
AUTOR(ES)
Whurr, R
RESUMO
Botulinum toxin injections have been used to treat 31 patients with adductor spasmodic dysphonia. Injections of 3.00-3.75 units of botulinum toxin were performed bilaterally into the thyroarytenoid muscle. This treatment significantly decreased the standard deviation of the fundamental frequency of the speech sample, indicating a reduction in the variability of pitch amongst patients. A total of 96% of patients' subjective diary reports showed an improvement with a median of 7 days to peak effect and a 5 week duration of peak effect.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1015013Documentos Relacionados
- Clinical aspects of spasmodic dysphonia.
- Spasmodic dysphonia and laryngeal botulinum toxin injection.
- Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm.
- Botulinum toxin treatment in spasmodic torticollis.
- Botulinum Toxin for Treatment of Spastic Dysphonia